The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons

Abroad (travel likely)Recruiting

Conditions

Endometrial Cancer · Endometrial Cancer Precursors · Ovarian Cancer · Complex Atypical Endometrial Hyperplasia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Rebecca Arend, MD, MSPH) · rarend@uabmc.edu · 205-934-5370

Study leads

Rebecca C Arend, MD, MSPH
Principal Investigator
University of Alabama at Birmingham

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Neoplasms

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Palo Alto, United States

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States

Distance-Based Exercise to Preserve Function and Prevent Disability

Localized Malignant Solid Neoplasm · Anal Cancer · Bladder (Urothelial, Transitional Cell) Cancer

Abroad (travel likely)Recruiting

Dublin, United States · Fremont, United States

A Study of PHST001 in Advanced Solid Tumors

Advanced Solid Tumors · Ovarian Cancer · Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1

Beverly Hills, United States · Los Angeles, United States